News-Medical.Net March 10, 2025
Versus Arthritis

A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.

Scientists from Newcastle University, with funding from Versus Arthritis, have developed a unique approach to bioprinting cell-filled gels that can closely mimic human tissues, earning it a patent in the US and Europe.

While bioprinting has been around for several years, it has had multiple limitations that the team, led by Professor Kenny Dalgarno, has overcome. Such is the promise of the discovery, they have set up a spin out company, Jetbio, to attract investment to roll out the ReJI printer for use in labs across the world.

The groundbreaking process, called Reactive Jet Impingement (ReJI)...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: 3D Printing, Biotechnology, Pharma, Pharma / Biotech, Technology
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article